A Physical and psychological aspect of school age children with major thalassemia
Physical and psychological aspect of school age children with major thalassemia
Background: Thalassemia is the one genetic disorder in the world, characterized by a reduction or absence of normal hemoglobin synthesis. It has an impact on the progress of growth and development, this leads to increase the worries about physical appearance. Objectives: the study aims to identify the quality of life in physical and psychological aspects of thalassemic school age children and those who are healthy and also aims to find out the comparison of the quality of life between school-age children who are sick with thalassemia and those who are healthy, in terms of physical and psychological aspects. Materials and Methods: Data obtained from February 12, 2024, to April 15, 2024; Part of the data was collected using a questionnaire and interview technique with participants who were interviewed individually in the hematology centre, healthy companions in the school unit in the hospital, by interviewing all participants and including the research sample in a similar way, and the same questionnaire was used in the same place to achieve the goals. Results: The results showed that the quality of life in the physical domain demonstrated that the probability of achieving a superior degree was significantly lower in patients with Thalassemia than in control 7 (14%) and 39 (78%) patients, respectively (P value <0.001). also the results found that the level of QoL in psychological aspect revealed that frequency of good level was lower in thalassemia patients compared to controls; 2 (4%) vs. 10 (20%), respectively, while poor QoL was more frequent in thalassemia group than control; 10% vs. 4%, respectively, (P. value = 0.030). Conclusions: There is a big difference in the quality of life between school-age children who are sick with thalassemia and those who are healthy, in terms of physical and psychological aspects. must conduct greater research and continuous follow-up to monitor the situation as required so that it does not deteriorate further, and support them from the ministries with treatment and psychological support from family and friends. And society and schools.
Downloads
Musallam KM, Cappellini MD, Viprakasit V, Kattamis A, Rivella S, Taher AT. Revisiting the non‐transfusion‐dependent (NTDT) vs. transfusion‐dependent (TDT) thalassemia classification 10 years later. Am J Hematol 2021;96:E54–6. https://doi.org/10.1002/ajh.26056.
Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, et al. Current status of beta‐thalassemia and its treatment strategies. Mol Genet Genomic Med 2021;9. https://doi.org/10.1002/mgg3.1788.
Khodaei GH, Farbod N, Zarif B, Nateghi S, Saeidi M. Frequency of Thalassemia in Iran and Khorasan Razavi. Int J Pediatr 2013;1:45–50.
Mettananda S, Higgs DR. Molecular Basis and Genetic Modifiers of Thalassemia. Hematol Oncol Clin North Am 2018;32:177–91. https://doi.org/10.1016/j.hoc.2017.11.003.
Mutsher AL-Mosooi D. Assessment of Health Quality of Life upon School Age Children (6-12 ) with Thalassemia at Thalassemia Centre in Ibn-Baladi Hospital. vol. 5. 2011.
Ismail DK, El-Tagui MH, Hussein ZA, Eid MA, Aly SM. Evaluation of health-related quality of life and muscular strength in children with beta thalassemia major. Egyptian Journal of Medical Human Genetics 2018;19:353–7. https://doi.org/10.1016/j.ejmhg.2018.04.005.
Hamdy M, Draz IH, El Sayed IT, Ayyad AAF, Salemd MR. Assessment of Quality of Life among Beta-Thalassemia Major Patients Attending the Hematology Outpatient Clinics at Cairo University Hospital. Open Access Maced J Med Sci 2021;9:156–60. https://doi.org/10.3889/oamjms.2021.5692.
Hossain MJ, Islam MW, Munni UR, Gulshan R, Mukta SA, Miah MS, et al. Health-related quality of life among thalassemia patients in Bangladesh using the SF-36 questionnaire. Sci Rep 2023;13:7734. https://doi.org/10.1038/s41598-023-34205-9.
Siddiqui SH, Ishtiaq R, Sajid F, Sajid R. Quality of life in patients with thalassemia major in a developing country. J Coll Physicians Surg Pak 2014;24:477–80.
Baker N, Alnakashabandi A, Alsaqy AH, Alrabaty A. Growth Pattern and Sexual Maturation Rate in β-Thalassemia Major Patients from Thalassemia Center Erbil. Iraqi Postgraduate Medical Journal 2013;12:40–4.
Pakbaz Z, Treadwell M, Yamashita R, QUIROLO K, FOOTE D, QUILL L, et al. Quality of Life in Patients with Thalassemia Intermedia Compared to Thalassemia Major. Ann N Y Acad Sci 2005;1054:457–61. https://doi.org/10.1196/annals.1345.059.
Cheuk DKL, Mok ASP, Lee ACW, Chiang AKS, Ha SY, Lau YL, et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant 2008;42:319–27. https://doi.org/10.1038/bmt.2008.165.
Al-Salehe QAA, Al-Awady MS, Abbass SK. Growth Retardation in β-Thalassemia Major. Iraqi Postgraduate Medical Journal 2015;14:267–73.
Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health related quality of life in Malaysian children with thalassaemia. Health Qual Life Outcomes 2006;4:39. https://doi.org/10.1186/1477-7525-4-39.
Copyright (c) 2025 International Journal of Body, Mind and Culture
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
